Sermorelin is a prescription medication intended for specific medical conditions, namely growth hormone deficiency or related diagnoses confirmed by a physician
The following data were collected: publication year, country and continent, study setting (e.g., hospital, private practice, academic clinic), sample size, age range, mean age, study design, population characteristics, intervention details, outcomes, and effect measures (e.g., serum B12 levels)
The common research schedule is 812 weeks on, then about 4 weeks off , letting the GH/IGF-1 axis and receptor sensitivity reset before another cycle
Versus full-length growth hormone Full-length human growth hormone causes numerous side effects that AOD 9604 specifically avoids: Blood sugar disruption : GH impairs insulin sensitivity and can precipitate diabetes in susceptible individuals
These timelines reflect typical clinical observations, not guaranteed outcomes